Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04570553 · ClinicalTrials.gov registry record · NA
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
A NA study of Endometrial Cancer, sponsored by WellSpan Health.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT04570553: Recruiting NA study of Endometrial Cancer, sponsored by WellSpan Health.
NCT04570553 is a NA study of Endometrial Cancer that is actively recruiting participants, run by WellSpan Health. The registered enrollment target is 350 participants, below the 522-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04570553, a NA study of Endometrial Cancer, is actively recruiting participants, sponsored by WellSpan Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
Primary Outcome
Intraoperative conversion rate from negative to positive peritoneal cytology will be assessed in each arm
Conditions Studied
Interventions
- PROCEDURE surgical staging
Study Locations (1)
Pennsylvania
- Wellspan Health - York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT04570553 shows while recruiting
NCT04570553 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 522-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which surgical staging is the first listed.
NCT04570553 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04570553 about?
NCT04570553 is a clinical study titled "Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers". This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
What is the current status of trial NCT04570553?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2020-10-15. Estimated completion is 2027-06-30.
What conditions does trial NCT04570553 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT04570553?
The interventions under investigation include: surgical staging (PROCEDURE).
Who is sponsoring clinical trial NCT04570553?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04570553 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04570553's enrollment target sits among peer trials
350 42nd of 181 higher than 140 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI